These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24976394)

  • 61. Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.
    Prisciandaro JJ; DeSantis SM; Chiuzan C; Brown DG; Brady KT; Tolliver BK
    Alcohol Clin Exp Res; 2012 Mar; 36(3):490-6. PubMed ID: 21933201
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quetiapine for alcohol use and craving in bipolar disorder.
    Longoria J; Brown ES; Perantie DC; Bobadilla L; Nejtek VA
    J Clin Psychopharmacol; 2004 Feb; 24(1):101-2. PubMed ID: 14709960
    [No Abstract]   [Full Text] [Related]  

  • 63. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
    Montgomery SA; Altamura AC; Katila H; Datto C; Szamosi J; Eriksson H
    Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.
    Garriga M; Solé E; González-Pinto A; Selva-Vera G; Arranz B; Amann BL; Saiz-Ruiz J; Pérez-Blanco J; Vieta E
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):959-969. PubMed ID: 28882405
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of quetiapine in the treatment of bipolar disorder.
    Pini S; Abelli M; Cassano GB
    Expert Opin Pharmacother; 2006 May; 7(7):929-40. PubMed ID: 16634715
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hospital stay in patients admitted for acute bipolar manic episodes prescribed quetiapine immediate or extended release: a retrospective non-interventional cohort study (HOME).
    Karamustafalıoğlu O; Reif A; Atmaca M; Gonzalez D; Moreno-Manzanaro M; Gonzalez MA; Medina E; Bellomo A
    BMC Psychiatry; 2014 Aug; 14():246. PubMed ID: 25174996
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapid quetiapine loading in youths with bipolar disorder.
    Scheffer RE; Tripathi A; Kirkpatrick FG; Schultz T
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):441-5. PubMed ID: 20973715
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
    J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.
    Suppes T; Kelly DI; Keck PE; McElroy SL; Altshuler LL; Mintz J; Frye MA; Nolen WA; Luckenbaugh DA; Post RM; Leverich GS; Kupka RW; Grunze H
    Int Clin Psychopharmacol; 2007 Nov; 22(6):376-81. PubMed ID: 17917557
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.
    Weisler R; Joyce M; McGill L; Lazarus A; Szamosi J; Eriksson H;
    CNS Spectr; 2009 Jun; 14(6):299-313. PubMed ID: 19668121
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: an open label study.
    Bahk WM; Yoon BH; Lee KU; Chae JH
    Hum Psychopharmacol; 2004 Apr; 19(3):181-5. PubMed ID: 15079852
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
    Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
    Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rapid titration versus conventional titration of quetiapine in the treatment of bipolar mania: a preliminary trial.
    Pae CU; Nassir Ghaemi S; Kim TS; Kim JJ; Lee SJ; Lee CU; Lee C; Paik IH
    Int Clin Psychopharmacol; 2005 Nov; 20(6):327-30. PubMed ID: 16192842
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
    Shajahan P; Taylor M
    J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
    Suppes T; Vieta E; Gustafsson U; Ekholm B
    Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.
    Suppes T; Hirschfeld RM; Vieta E; Raines S; Paulsson B
    World J Biol Psychiatry; 2008; 9(3):198-211. PubMed ID: 17853277
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Add-on quetiapine for bipolar depression: a 12-month open-label trial.
    Milev R; Abraham G; Zaheer J
    Can J Psychiatry; 2006 Jul; 51(8):523-30. PubMed ID: 16933589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.